Hpv Vaccine Cervical Cancer Rates, Paradoxical Effect Of Anti Hpv Vaccine Gardasil On Cervical Cancer Rate Docteur Nicole Delepine

In 2006 a vaccine became available in the united states that can protect against the types of hpv that most commonly cause cervical cancer.

Pfizer news release. Protects again 4 types of hpv hpv 16 and 18 which together cause around 7 in 10 cervical cancer cases in the uk and hpv 6 and 11 which cause most genital warts. Knowledge regarding cervical cancer and hpv vaccine was 238 times more in mbbs iii year subjects than compared to mbbs ii year p 00001. This is because even if hpv vaccination were to eradicate hpv types 16 18 31 33 45 52 and 58 a proportion of lmics mainly in sub saharan africa would still have cervical cancer incidence greater than the threshold of four cases per 100 000 women years.

The vaccine protects against human papillomavirus hpv which causes most strains of cervical cancer. Black and hispanic women had higher rates of hpv associated cervical cancer than women of other races and non hispanic women. Some types of hpv can cause warts and other hpv types can lead to cancer.

Hpv vaccines are vaccines that protect against infection with human papillomaviruses hpv. The vaccine targets several strains of human papilloma virus hpv including strains 16 and 18 which cause most cervical cancers. Descriptive statistics chi square test and regression method were used to analyze the study data with p 005 considered as statistically significant.

Hpv can also cause genital warts and some other types of cancer. Hpv is a group of more than 200 related viruses of which more than 40 are spread through direct sexual contactamong these two hpv types cause genital warts and about a dozen hpv types can cause certain types of cancercervical anal oropharyngeal penile vulvar and vaginal. Proportion of subjects willing for.

The hpv vaccine appears to be working. It is estimated that about 900 new cases of hpv associated vaginal cancer and 4100 new cases of hpv associated vulvar cancer are diagnosed in the united states each year. The vaccines are recommended for boys and girls starting at age 11 to 12 years.

Researchers compared infection rates before and after introduction of the vaccine for both teens 13 to 19 years and young adults 20 to 24 years. We assessed the association between hpv vaccination and the risk of invasive cervical cancer controlling for age at follow up calendar year county of residence and parental characteristics. Countries with vaccination programmes are lowering the rate of virus infection precancerous lesions and genital warts in girls and womenboys and men are.

In 2008 routine hpv immunisation of 12 and 13 year old girls was introduced in schools.